Patents by Inventor Kanji Hori

Kanji Hori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200116714
    Abstract: To provide a device capable of cancer diagnosis with high sensitivity and specificity, a cancer diagnosis device (1) includes: an extracellular vesicle capturing section (16 to 18) including immobilization supports on which lectins are immobilized respectively, the lectins being each capable of binding specifically to a surface sugar chain included in an extracellular vesicle derived from a cancer cell, the immobilization supports corresponding respectively to one or more kinds of the surface sugar chain; and a detecting section configured to detect a microRNA included in the extracellular vesicle.
    Type: Application
    Filed: November 11, 2019
    Publication date: April 16, 2020
    Inventors: Kanji HORI, Makoto HIRAYAMA, Ikuro MARUYAMA, Yoshihiro TAGUCHI, Hiroshi KUROKAWA, Kenya KOBAYASHI, Hiroyoshi MINAKUCHI
  • Publication number: 20140087395
    Abstract: The object was to provide a method for distinguishing between species within the genus Staphylococcus; binding affinities between many types of lectins and bacteria belonging to the genus Staphylococcus were examined; and lectins of Tachylectin-2, LEL, KAA1, BCL11, CBA, HAA, HPA, STL, proBCA1, proBCA2, ULL, DSA, PWM, UDA, WFL, hypninA3, BCL11d, CFA1, CFA2, CLA, MPA1, MPA2, AC-avranin, algCSA, BML11b, BML11c, etc. were selected. Further, it was found that these lectins could be used to distinguish between species within the genus Staphylococcus.
    Type: Application
    Filed: March 22, 2012
    Publication date: March 27, 2014
    Applicants: HIROSHIMA UNIVERSITY, GLYENCE CO., LTD.
    Inventors: Hideaki Takeuchi, Koji Imamura, Uichiro Yabe, Kanji Hori, Makoto Hirayama
  • Patent number: 7867732
    Abstract: In one embodiment of the present application, a polypeptide capable of binding to a sugar chain is disclosed, particularly a high-mannose-type sugar chain bound to an antibody, more preferably a sugar chain bound to a chicken antibody. Also disclosed is a method for the purification of an antibody (specifically a chicken antibody) as a representative application of the polypeptide. Further disclosed is means for the purification. The polypeptide, BML-17, is a novel lectin made of 168 amino acid residues isolated from Bryopsis maxima. By using BML-17, it becomes possible to purify an antibody (e.g., a chicken antibody) readily and with high efficiency.
    Type: Grant
    Filed: February 27, 2006
    Date of Patent: January 11, 2011
    Assignee: National University of Corporation Hiroshima University
    Inventors: Kanji Hori, Haruo Matsuda
  • Publication number: 20090035818
    Abstract: In one embodiment of the present application, a polypeptide capable of binding to a sugar chain is disclosed, particularly a high-mannose-type sugar chain bound to an antibody, more preferably a sugar chain bound to a chicken antibody. Also disclosed is a method for the purification of an antibody (specifically a chicken antibody) as a representative application of the polypeptide. Further disclosed is means for the purification. The polypeptide, BML-17, is a novel lectin made of 168 amino acid residues isolated from Bryopsis maxima. By using BML-17, it becomes possible to purify an antibody (e.g., a chicken antibody) readily and with high efficiency.
    Type: Application
    Filed: February 27, 2006
    Publication date: February 5, 2009
    Inventors: Kanji Hori, Haruo Matsuda